Add BrightSurf on Google Email

Custom program helps people living with diabetes control blood sugar, weight

A customized WeightWatchers program has been shown to effectively manage Type 2 diabetes by lowering blood glucose levels and promoting significant weight loss. Participants in the six-month clinical trial experienced improved glycemic control and overall well-being, with clinically meaningful and statistically significant results.

SourcePennington Biomedical Research Center·JournalDiabetes·TypeRandomized controlled/clinical trial·DateJun 4, 2022

Study shows that excessively high BMI is also associated with type 1 diabetes in otherwise healthy adolescents – not just the type 2 form usually associated with excess weight

A nationwide study found a significant association between excessive BMI in late adolescence and the development of type 1 diabetes in young adulthood. The researchers analyzed data from over 1.4 million adolescents and found that those with obesity had double the risk of developing type 1 diabetes compared to those with optimal BMI.

SourceDiabetologia·JournalDiabetologia·DateJun 4, 2022

Oregon State research sheds light on why not all obese patients develop type 2 diabetes

Researchers at Oregon State University have developed a new analytical method that reveals why some obese patients develop type 2 diabetes while others don't. The study found that a particular type of gut microbe leads to insulin resistance, and treatments targeting microbiota may be a new therapeutic strategy for the disease.

SourceOregon State University·JournalJournal of Experimental Medicine·TypeExperimental study·DateJun 3, 2022

What will it take to transform obesity care for all?

The US healthcare system faces a significant challenge in providing high-quality, personalized obesity care due to lack of insurance coverage for effective medications and societal stigma. Recent efforts aim to address this issue through framework development and policy changes, which may lead to improved patient outcomes and cost savi...

SourceMichigan Medicine - University of Michigan·JournalPrimary Health Care Research & Development·TypeObservational study·DateMay 31, 2022

Obesity-related fertility issues may be improved by correcting blood sugar levels

A recent study published in the Journal of Endocrinology suggests that lowering blood glucose levels can partially restore reproductive hormone levels and ovulation in female mice with obesity. The study used dapagliflozin, a common type 2 diabetes medication, to treat the mice, resulting in improved fertility outcomes.

SourceSociety for Endocrinology·JournalJournal of Endocrinology·TypeExperimental study·DateMay 25, 2022

Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals

A landmark trial found that a widely used diabetes drug, metformin, is not effective against the most common forms of early-stage breast cancer. However, researchers discovered a potential benefit for individuals with HER2-positive breast cancer, which accounts for about 20% of all breast cancers.

SourceLunenfeld-Tanenbaum Research Institute·JournalJAMA·TypeRandomized controlled/clinical trial·DateMay 24, 2022

Type 2 diabetes accelerates brain aging and cognitive decline

A study published in eLife found that type 2 diabetes speeds up the normal process of brain aging, with longer duration of diabetes linked to increased neurodegeneration. The analysis showed that people with diabetes had a further 13.1% decrease in executive function and processing speed compared to healthy individuals.

SourceeLife·JournaleLife·DateMay 24, 2022

Contraceptive counseling and provision in clinical practice increases its use and reduces unintended pregnancy

A review of 38 randomized controlled trials found that counseling patients about contraceptive use and providing contraceptives increases use without increasing STI risk or reducing condom use. The interventions also decrease unintended pregnancy in trials designed to evaluate this outcome.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeMeta-analysis·DateMay 23, 2022

New Expert Consensus Statement published on achieving remission of type 2 diabetes using diet as a primary intervention

A panel of 15 experts reached consensus on 69 statements related to using diet as a primary intervention to achieve diabetes remission. The expert consensus statement emphasizes the effectiveness of whole, plant-based foods in achieving remission without medications or procedures.

SourceAmerican College of Lifestyle Medicine·JournalAmerican Journal of Lifestyle Medicine·DateMay 18, 2022

Indiana University School of Public Health-Bloomington faculty member co-authors meta-analysis of data on red meat and diabetes

A meta-analysis published in the European Journal of Clinical Nutrition found that diets containing red meat did not impact glycemic and insulinemic risk factors for type 2 diabetes. The study suggests that more research is needed to fully understand the relationship between red meat consumption and the development of type 2 diabetes.

SourceIndiana University School of Public Health·JournalEuropean Journal of Clinical Nutrition·DateMay 11, 2022

Combination of drugs for obesity and Type 2 diabetes may be more effective than a single therapy

Canadian and German researchers have identified personalized prescriptions that combine drugs to treat obesity and Type 2 diabetes. The combination therapy shows higher effectiveness in some patients and fewer side effects compared to single drugs. Studies are now needed to understand why individuals respond differently to the treatment.

SourceUniversity of Alberta·JournalFrontiers in Endocrinology·DateMay 3, 2022

Around three quarters of the total obesity costs to the US healthcare system among people living with obesity are accounted for by the 20% highest-cost cases

Research shows that around three quarters of total US healthcare costs for people with obesity are accounted for by the 20% highest-cost cases. These high-cost individuals had substantially more obesity-related complications and economic burden than those in lower cost categories.

Living near fast food restaurants in South Asia may increase risk of Type 2 diabetes

A new study published in PLOS Medicine found that living near fast food restaurants increases the risk of developing Type 2 diabetes. The research, conducted in Bangladesh and Sri Lanka, linked cross-sectional health data with environment mapping surveys to examine the associations between the density and proximity of healthy and unhea...

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateApr 26, 2022

New study reveals that healthy plant-based diets are associated with a lower risk of developing diabetes

A new study published in Diabetologia found that healthy plant-based diets, including fruits, vegetables, and legumes, are linked to a lower risk of developing type 2 diabetes. The study analyzed metabolite profiles and diet indices from over 10,684 participants, revealing unique multi-metabolite profiles associated with healthy plant-...

SourceDiabetologia·JournalDiabetologia·DateApr 8, 2022

Higher blood fats more harmful than first thought

Researchers discovered that elevated blood fats in people with metabolic diseases create stress in muscle cells, leading to cell death and worsening the illness. Ceramides, a signal created by stressed-out cells, can be passed on to other cells, increasing the risk of severe symptoms.

SourceUniversity of Leeds·JournalNature Communications·DateApr 1, 2022

Paternal metformin use associated with major birth defects if used during period of sperm development

A large cohort study found that babies born to men who took metformin during sperm development were at increased risk for genital defects in boys. Diabetes control affects sperm quality, so men should discuss alternative treatments with their doctors before conception. The findings suggest a need for further study on treatment of prosp...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateMar 28, 2022

Innovative AI technology aids personalized care for diabetes patients needing complex drug treatment

Researchers developed an AI method to analyze electronic health record data and predict optimal drug regimens for type 2 diabetes patients with similar characteristics. The algorithm successfully supported medication selection for over 83% of patients, leading to better management of the disease and improved patient engagement.

SourceRegenstrief Institute·JournalJournal of Biomedical Informatics·DateMar 25, 2022

Origins of diabetes may be different in men and women, according to new Concordia research

Researchers found that different regions of fat tissue contribute to disease risk differently in men and women, with visceral fat in men and subcutaneous fat in women being linked to diabetes onset. The study suggests that understanding these sex-specific differences can inform better clinical approaches to treating the disease.

SourceConcordia University·JournalObesity Reviews·TypeLiterature review·DateMar 23, 2022

Physiological effects of peripheral amyloid-β elucidated - Type 2 diabetes seen as major risk to development of Alzheimer’s disease

Researchers identified peripheral tissues as source of blood amyloid beta, which regulates blood glucose levels and suppresses insulin secretion. The study suggests a possible mechanism linking type 2 diabetes to Alzheimer's disease development.

SourceOsaka City University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 14, 2022

Chronic lactate exposure leads to cellular disruptions implicated in cancer and possibly T2 diabetes

Researchers found that chronic lactate exposure can lead to cellular disruptions, decreased fatty acid transport, and alterations of mitochondrial membranes, which may contribute to the development of heart failure and type 2 diabetes. The study suggests that lactate accumulation could be a major player in disease progression.

SourceUniversity of Colorado Anschutz Medical Campus·JournalFrontiers in Nutrition·TypeMeta-analysis·DateMar 10, 2022